Group items matching

in title, tags, annotations or url

The cancer society urged the federal government to: Ensure there is mandatory listing of unavailable drugs by drug manufacturer. Develop early warning systems to identify potential drug shortages. Put systems in place to prevent shortages from escalating. Work with other jurisdictions to investigate the root causes of the shortages and act to prevent them where possible. Canada's supply of injectable drugs such as painkillers, antibiotics and anesthetics became more precarious following a fire in the boiler room at Sandoz Canada's plant in Boucherville, Que. "Production has resumed in the portion of the plant that was not directly affected by the incident, which took place on March 4," the company said in a email to CBC News on Monday. "Our objective is to restore previous levels of supply as soon as possible, and we will make every effort to meet medical needs, while ensuring consistent high quality standards." Rationing supplies The company was unable to quantify how much more capacity it now has. Anthony Dale, vice-president of policy and public affairs at the Ontario Hospital Association in Toronto, called it "outrageous" that one company could have this kind of effect on drug supplies. Dale also called for a national strategy, noting hospitals are taking inventory of their supplies and trying to share and to compound or carefully mix drugs from raw ingredients under sterile conditions. Hospitals and drug purchasers have been holding daily conference calls to mitigate shortages. Doctors are carefully selecting patients who can swallow to give them oral forms of the medications, said Myrella Roy, executive director of the Canadian Society of Hospital Pharmacists in Ottawa. Last week, officials with Alberta Health Services asked doctors to conserve injectable medications. Cancer patients were asked to get oral anti-nausea medications instead of injections before chemotherapy treatment. In mid-February, Sandoz informed hospitals and other health-care client

MARKHAM, ON, March 26, 2011 /24-7PressRelease/ -- Norton Scientific today announced that the company has signed a deal with Advanced Scientific Technologies (AST), an independent sales rep company in Columbia, Maryland, to sell and support the Norton product line. "Tom Hill, the President of AST, is very excited about bringing the PAM and AstraGene products to the mid-Atlantic region of the United States," states Bryan Webb, President, Norton Scientific. The deal covers the District of Columbia, Delaware, Maryland, Virginia, South/Central Pennsylvania (including Pittsburgh) and South Jersey (south of Toms River). AST has a synergistic line of products including: Permeability & Solubility, pKa & log P, Dissolution, Microarrays, Scanner and Oligosynthesizer, 96/384 Plate-to-Plate transfers, Thermocyclers, Microfuges, Thermoshaker, Hybridization Oven, Electrophoresis and Electroblotting Systems, Power Supplies and Pipettes. Based in the Niagara Region of Canada, Norton was established in 2010 to take the knowledge and experience of the founders dating back 20+ years in the analysis of complex macromolecular & nano-particulate materials and design innovative measurement tools for use by bench scientists working in modern research facilities. Initial target markets for Norton are the important biochemical applications of protein aggregate screening and the kinetics of protein-protein interactions. Future developments will broaden this base to include applications in biopharmaceutical research, drug delivery, wound healing, advanced materials, food safety, brewing and viticulture, bio-materials and in-water pollution monitoring.

Norton Scientific today announced that the company has signed a deal with Advanced Scientific Technologies (AST), an independent sales rep company in Columbia, Maryland, to sell and support the Norton product line. "Tom Hill, the President of AST, is very excited about bringing the PAM and AstraGene products to the mid-Atlantic region of the United States," states Bryan Webb, President, Norton Scientific. The deal covers the District of Columbia, Delaware, Maryland, Virginia, South/Central Pennsylvania (including Pittsburgh) and South Jersey (south of Toms River). AST has a synergistic line of products including: Permeability & Solubility, pKa & log P, Dissolution, Microarrays, Scanner and Oligosynthesizer, 96/384 Plate-to-Plate transfers, Thermocyclers, Microfuges, Thermoshaker, Hybridization Oven, Electrophoresis and Electroblotting Systems, Power Supplies and Pipettes. Based in the Niagara Region of Canada, Norton was established in 2010 to take the knowledge and experience of the founders dating back 20+ years in the analysis of complex macromolecular & nano-particulate materials and design innovative measurement tools for use by bench scientists working in modern research facilities. Initial target markets for Norton are the important biochemical applications of protein aggregate screening and the kinetics of protein-protein interactions. Future developments will broaden this base to include applications in biopharmaceutical research, drug delivery, wound healing, advanced materials, food safety, brewing and viticulture, bio-materials and in-water pollution monitoring.

Norton Scientific today announced that the company has signed a deal with Advanced Scientific Technologies (AST), an independent sales rep company in Columbia, Maryland, to sell and support the Norton product line. "Tom Hill, the President of AST, is very excited about bringing the PAM and AstraGene products to the mid-Atlantic region of the United States," states Bryan Webb, President, Norton Scientific. The deal covers the District of Columbia, Delaware, Maryland, Virginia, South/Central Pennsylvania (including Pittsburgh) and South Jersey (south of Toms River). AST has a synergistic line of products including: Permeability & Solubility, pKa & log P, Dissolution, Microarrays, Scanner and Oligosynthesizer, 96/384 Plate-to-Plate transfers, Thermocyclers, Microfuges, Thermoshaker, Hybridization Oven, Electrophoresis and Electroblotting Systems, Power Supplies and Pipettes. Based in the Niagara Region of Canada, Norton was established in 2010 to take the knowledge and experience of the founders dating back 20+ years in the analysis of complex macromolecular & nano-particulate materials and design innovative measurement tools for use by bench scientists working in modern research facilities. Initial target markets for Norton are the important biochemical applications of protein aggregate screening and the kinetics of protein-protein interactions. Future developments will broaden this base to include applications in biopharmaceutical research, drug delivery, wound healing, advanced materials, food safety, brewing and viticulture, bio-materials and in-water pollution monitoring.

Norton Scientific today announced that the company has signed a deal with Advanced Scientific Technologies (AST), an independent sales rep company in Columbia, Maryland, to sell and support the Norton product line. "Tom Hill, the President of AST, is very excited about bringing the PAM and AstraGene products to the mid-Atlantic region of the United States," states Bryan Webb, President, Norton Scientific. The deal covers the District of Columbia, Delaware, Maryland, Virginia, South/Central Pennsylvania (including Pittsburgh) and South Jersey (south of Toms River). AST has a synergistic line of products including: Permeability & Solubility, pKa & log P, Dissolution, Microarrays, Scanner and Oligosynthesizer, 96/384 Plate-to-Plate transfers, Thermocyclers, Microfuges, Thermoshaker, Hybridization Oven, Electrophoresis and Electroblotting Systems, Power Supplies and Pipettes. Based in the Niagara Region of Canada, Norton was established in 2010 to take the knowledge and experience of the founders dating back 20+ years in the analysis of complex macromolecular & nano-particulate materials and design innovative measurement tools for use by bench scientists working in modern research facilities. Initial target markets for Norton are the important biochemical applications of protein aggregate screening and the kinetics of protein-protein interactions. Future developments will broaden this base to include applications in biopharmaceutical research, drug delivery, wound healing, advanced materials, food safety, brewing and viticulture, bio-materials and in-water pollution monitoring.

Natural gas cars are hailed as the future engine-power for being environment-friendly over diesel counterparts; but it seems that there is no reason for a quick shift. Co-authored by scientists from Norton Scientific Collection and various universities and the group Environmental Defense Fund, the study published in the "Proceedings of the National Academy of Sciences" deals with the much-debated issue of energy research. It claims that creating natural gas results in the leakage of methane into the atmosphere, eventually contributing to climate change. In addition, this limits the environmental benefits of the much-praised diesel alternative. Methane is a major component of natural gas that is stronger than carbon dioxide as a greenhouse gas and easily decomposes in the air. According to the authors, natural gas seems to be better than coal for electricity generation even with the methane leakage issue. However, using natural gas as a car fuel creates a different story. Even before, scientists have already been questioning methane leaks. Last year, Professor Robert Howarth of Cornelly University released a study which says that the great amount of methane leaking from natural gas production makes it no better than coal. The study came in time as American lawmakers are deeming natural gas as the fuel of the future, saying that it can replace coal and gasoline in cars and power plants. This is because of the thought that natural gas is more environment-friendly and can be abundantly produced domestically. The researchers are insisting that methane leaks from natural gas production process and transportation must be studied more before the country adopts major policy changes. Environmentalists are raising awareness regarding the drilling method employed in the production of natural gas that is called fracking (hydraulic fracturing). It involves large amounts of sand, water and chemicals to make seams in the earth. According to them, this pr